Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25799

1.

Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study.

Xu J, Lv TT, Zhou XF, Huang Y, Liu DD, Yuan GL.

Medicine (Baltimore). 2018 Sep;97(39):e12102. doi: 10.1097/MD.0000000000012102.

2.

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and mTOR/ P70S6K/4EBP1 Signaling.

Jin J, Hu K, Ye M, Wu D, He Q.

Cell Physiol Biochem. 2018;48(2):765-772. doi: 10.1159/000491905. Epub 2018 Jul 19.

3.

Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature.

Wang X, Zhang S, Li L, Hua J, Zhu L, Li L, Zhang G.

Medicine (Baltimore). 2018 Jun;97(26):e11206. doi: 10.1097/MD.0000000000011206. Review.

4.

Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies.

Khalil MMI, Messner HA, Lipton JH, Kim DD, Viswabandya A, Thyagu S, Deotare U, Michelis FV.

Ann Hematol. 2018 Oct;97(10):1975-1985. doi: 10.1007/s00277-018-3391-9. Epub 2018 Jun 11.

PMID:
29947975
5.

Point: Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL.

Thompson PA, Tam CS.

Oncology (Williston Park). 2018 Jun;32(6):291-2, 294-6. No abstract available.

6.

Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease.

Nicolau JC, Baracioli LM, Giugliano RP.

Expert Opin Pharmacother. 2018 Jun;19(9):1013-1019. doi: 10.1080/14656566.2018.1476491. Epub 2018 Jun 12. Review.

PMID:
29893152
7.

Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography.

Kim C, Kim BK, Hong SJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y.

Yonsei Med J. 2018 Jul;59(5):624-632. doi: 10.3349/ymj.2018.59.5.624.

8.

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

Egle A, Steurer M, Melchardt T, Weiss L, Gassner FJ, Zaborsky N, Geisberger R, Catakovic K, Hartmann TN, Pleyer L, Voskova D, Thaler J, Lang A, Girschikofsky M, Petzer A, Greil R.

Ann Hematol. 2018 Oct;97(10):1825-1839. doi: 10.1007/s00277-018-3380-z. Epub 2018 Jun 4. Erratum in: Ann Hematol. 2018 Jun 23;:.

9.

DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.

Yang SY, Li Y, An GS, Ni JH, Jia HT, Li SY.

Int J Mol Sci. 2018 May 28;19(6). pii: E1587. doi: 10.3390/ijms19061587.

10.

Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine.

Haanes KA, Labastida-Ramírez A, Chan KY, de Vries R, Shook B, Jackson P, Zhang J, Flores CM, Danser AHJ, Villalón CM, MaassenVanDenBrink A.

J Headache Pain. 2018 May 25;19(1):41. doi: 10.1186/s10194-018-0867-x.

11.

Extracellular NAD+ Suppresses Adrenergic Effects in the Atrial Myocardium of Rats during the Early Postnatal Ontogeny.

Pustovit KB, Ivanova AD, Kuz'min VS.

Bull Exp Biol Med. 2018 May;165(1):1-4. doi: 10.1007/s10517-018-4085-y. Epub 2018 May 24.

PMID:
29797136
12.

Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine.

Liang D, Woo JI, Shao H, Born WK, O'Brien RL, Kaplan HJ, Sun D.

PLoS One. 2018 May 17;13(5):e0197189. doi: 10.1371/journal.pone.0197189. eCollection 2018.

13.

Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia.

Cai Y, Feng L, Wang X.

Crit Rev Oncol Hematol. 2018 Jun;126:24-31. doi: 10.1016/j.critrevonc.2018.03.022. Epub 2018 Mar 29. Review.

PMID:
29759563
14.

Mechanisms of acetylcholinesterase protection against sarin and soman by adenosine A1 receptor agonist N6-cyclopentyladenosine.

Beste A, Taylor DE, Shih TM, Thomas TP.

Comput Biol Chem. 2018 Aug;75:74-81. doi: 10.1016/j.compbiolchem.2018.04.017. Epub 2018 May 7.

PMID:
29747078
15.

Semisynthesis, Characterization and Evaluation of New Adenosine Derivatives as Antiproliferative Agents.

Valdés Zurita F, Brown Vega N, Gutiérrez Cabrera M.

Molecules. 2018 May 8;23(5). pii: E1111. doi: 10.3390/molecules23051111.

16.

Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.

Liu T, Yang H, Fan W, Tu J, Li TWH, Wang J, Shen H, Yang J, Xiong T, Steggerda J, Liu Z, Noureddin M, Maldonado SS, Annamalai A, Seki E, Mato JM, Lu SC.

Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5.

PMID:
29733835
17.
18.

Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.

Tamura R, Doi S, Nakashima A, Sasaki K, Maeda K, Ueno T, Masaki T.

PLoS One. 2018 May 3;13(5):e0196844. doi: 10.1371/journal.pone.0196844. eCollection 2018.

19.

Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.

Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X.

JAMA. 2018 Apr 24;319(16):1677-1686. doi: 10.1001/jama.2018.3197.

PMID:
29710164
20.

Extracellular adenosine modulates host-pathogen interactions through regulation of systemic metabolism during immune response in Drosophila.

Bajgar A, Dolezal T.

PLoS Pathog. 2018 Apr 27;14(4):e1007022. doi: 10.1371/journal.ppat.1007022. eCollection 2018 Apr.

Supplemental Content

Loading ...
Support Center